156.35USD-0.23%Mkt Cap: 15.76B USDP/E: 24.11Last update: 2026-05-26
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products i…
Industry Peers
Drug Manufacturers - Specialty & Generic152.45BSEKP/E 166.3
58.11BTRYP/E 27.8
55.80BEURP/E 22.1
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
13.30BEURP/E 30.3
12.92BSEKP/E 39.1
Indicators:|
Key Statistics
Company
Market Cap15.76B USD
Enterprise Value14.78B USD
Revenue (TTM)3.10B USD
Gross Profit2.81B USD
Net Income (TTM)478.60M USD
Revenue/Share31.12 USD
Last Price156.35 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS64125C1099
Valuation
P/E (Trailing)24.11
P/E (Forward)12.24
PEG0.44
EV/EBITDA17.84
EV/Revenue4.76
P/S5.04
P/B4.59
EPS (TTM)6.50
EPS (Forward)12.71
52W Range
117.5987% of range162.39
52W High162.39 USD
52W Low117.59 USD
Profitability
Gross Margin98.18%
Oper. Margin22.84%
EBITDA Margin26.71%
Profit Margin16.73%
ROE14.71%
ROA10.33%
Growth
Revenue Growth42.20%
Earnings Growth2310.50%
Cash Flow & Leverage
Operating CF782.70M USD
CapEx (TTM)34.00M USD
FCF Margin19.04%
FCF Yield3.75%
Net Debt-852.70M USD
Net Debt/EBITDA-1.03
Balance Sheet
Debt/Equity0.13
Current Ratio2.93
Quick Ratio2.51
Book Value/Sh33.87 USD
Cash/Share13.09 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateDec 29, 1995
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)190.99 USD
Target Range144.00 USD – 250.65 USD
# Analysts27
Ownership
Shares Out.100.55M
Float99.26M
Insiders1.09%
Institutions103.48%
Short Interest
Short Ratio5.1d
Short % Float7.76%
Short % Out.5.96%
Shares Short5.99M
Short (prev mo.)4.56M
Technical
SMA 50136.23 (+14.8%)
SMA 200138.72 (+12.7%)
Beta0.34
S&P 52W Chg28.31%
Avg Vol (30d)1.23M
Avg Vol (10d)1.28M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—